Health officials involved in coronavirus vaccine clinical trials said that the drugs weren’t designed to stop the spread of COVID-19. The goal was to prevent severe COVID-19 cases and deaths. Preventing infection would >>
Pfizer News
It turns out we might need 3 coronavirus vaccine shots instead of 2 – here’s why
As more contagious COVID variants spread across the US, Pfizer is exploring the utility of a third booster dose. Pfizer hopes that a third vaccine dose might “raise the antibody response 10 to >>
Pfizer has some great news about its supply of coronavirus vaccine doses
Pfizer is planning to deliver 200 million COVID vaccine doses to the US by May. Pfizer has managed to ramp up vaccine production significantly in recent weeks. Early on, Pfizer didn’t think it >>
Study says Pfizer vaccine immunity is so strong, it might prevent COVID-19 transmission
A study from Israel indicates that people who received the Pfizer/BioNTech coronavirus vaccine develop an immune response significantly stronger than COVID-19 survivors. These researchers think this sort of immunity might completely prevent COVID-19 >>
Pfizer’s coronavirus vaccine is 90% effective so far – but there’s one crucial problem
The Pfizer coronavirus vaccine is even more effective than experts had hoped, according to interim data released earlier this week. Figures may change, but Pfizer seems to be on track to be the >>
Here’s a rough idea of when you can expect to get Pfizer’s breakthrough COVID-19 vaccine
HHS Secretary Alex Azar has given a rough outline regarding how and when the Pfizer vaccine to fight COVID-19 will start being distributed. In an interview with NBC’s TODAY show, Azar said among >>
These promising coronavirus vaccines could be approved sooner than expected – but not in the US
The UK has accelerated the review of the three coronavirus vaccine frontrunners: AstraZeneca, Moderna, and Pfizer. The country’s government is conducting rolling reviews, which allow it to see data in real-time and potentially >>
We have to wait longer than expected for coronavirus vaccine trial results – but that might be great news
Coronavirus vaccine candidate maker Pfizer was expected to release early efficacy results for Phase 3 in mid-October, ahead of the presidential election. That’s no longer the case, as the first efficacy data isn’t >>
